Seattle Genetics, Inc.

(NASDAQ:SGEN)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period — 59,644 59,644 9,137
Cash At End Of Period — 34,908 115,123 59,644
Net Change In Cash And Cash Equivalents — -24,736 55,479 50,507
Effect Of Exchange Rate Changes — — — —
Net Income Or Loss — -33,140 -17,112 -48,932
Cash From Operating Activities
Depreciation Expenses — 1,609 774 2,548
Amortization Expenses — 467 71 —
Amortization Of Intangibles Expenses — — — —
Deferred Income Taxes — — — —
Operating Gains Or Losses — — — -707
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables — -2,805 -2,146 -5,309
Increase Or Decrease In Inventories — — — —
Increase Or Decrease In Prepaid Expenses — -5,679 -188 -14
Increase Or Decrease In Other Current Assets — -5,679 -188 -14
Increase Or Decrease In Payables — — — —
Increase Or Decrease In Other Current Liabilities — 1,338 -420 4,255
Increase Or Decrease In Other Working Capital — — — —
Other Non Cash Items — 5,535 4,497 80,100
Net Cash From Continuing Operations — 5,792 3,225 7,889
Net Cash From Discontinued Operations — -26,883 -11,299 39,830
Net Cash From Operating Activities — — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — —
Sale Of Long Term Investments — — — —
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment — -2,671 -1,114 -4,283
Acquisitions — — — —
Purchase Of Long Term Investments — — — —
Purchase Of Short Term Investments — -133,239 -57,964 -185,917
Other Investing Changes Net — — — —
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities — -96,895 -31,997 4,073
Cash From Financing Activities
Issuance Of Debt — 99,042 98,775 6,604
Issuance Of Capital Stock — — — —
Repayment Of Debt — — — —
Repurchase Of Capital Stock — — — —
Payment Of Cash Dividends — — — —
Net Other Financing Charges — — — —
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities — 99,042 98,775 6,604